← FDA DRUG APPROVALS

FDA ANDA · ANDA207231

ILOPERIDONE

Sponsor: INVENTIA

APPLICATION
ANDA207231
TYPE
ANDA
ORIGINAL APPROVAL
2016-11-28
LATEST ACTION
2020-09-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ILOPERIDONEDiscontinued
ILOPERIDONE 10MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 6MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 2MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 12MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 8MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 4MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 1MG · TABLET · ORAL

Approval history

2020-09-11Labeling · Supplement 2 · standardAP
2020-01-27Labeling · Supplement 1 · standardAP
2016-11-28UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →